|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of assets | |||||
| Stock-based compensation expense | |||||
| Loss on disposal of property and equipment | |||||
| Goodwill impairment | |||||
| Provision for accounts receivable credit losses | |||||
| Amortization of debt issuance cost and debt discount | |||||
| Change in fair value of contingent consideration | |||||
| (Gain) impairment of minority investments | |||||
| Change in contingent consideration | |||||
| Realized gain on available-for-sale financial investments | |||||
| Equity earnings on investments | |||||
| Benefit for deferred income taxes | |||||
| Gain on investment | |||||
| Gain on Cboe Digital non-recourse notes and warrants wind down | |||||
| Other loss (gain) adjustments, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Restricted cash and cash equivalents and customer bank deposits (included in margin deposits, clearing funds, and interoperability funds) | |||||
| Income taxes receivable | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Section 31 fees payable | |||||
| Deferred revenue | |||||
| Income taxes payable | |||||
| Unrecognized tax benefits | |||||
| Other liabilities | |||||
| Net cash flows provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from investments | |||||
| Contributions to investments | |||||
| Purchases of available-for-sale financial investments | |||||
| Proceeds from maturities of available-for-sale financial investments | |||||
| Proceeds from sale of intangible assets | |||||
| Proceeds from sale of property held for sale | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from notes receivable | |||||
| Proceeds from insurance | |||||
| Purchases of property and equipment and leasehold improvements, net | |||||
| Net cash flows provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from long-term debt | |||||
| Principal payments of current portion of long-term debt | |||||
| Debt issuance costs | |||||
| Cash dividends on common stock | |||||
| Repurchases of common stock from employee stock plans | |||||
| Shares issued under employee stock purchase plan | |||||
| Payments of contingent consideration related to acquisitions | |||||
| Payments for Cboe Digital non-recourse notes and warrants wind down | |||||
| Purchase of common stock, including commissions and excise taxes | |||||
| Net cash flows used in financing activities | |||||
| Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash and cash equivalents | |||||
| Increase in cash, cash equivalents, and restricted cash and cash equivalents | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosure of cash transactions: | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of noncash investing activities: | |||||
| Accounts receivable acquired | |||||
| Financial investments acquired | |||||
| Other current assets acquired | |||||
| Goodwill acquired | |||||
| Intangible assets earned or acquired | |||||
| Property and equipment, net acquired | |||||
| Data processing software and other assets acquired | |||||
| Operating lease right of use asset acquired | |||||
| Accounts payable and accrued liabilities assumed | |||||
| Deferred revenue acquired | |||||
| Operating lease liability - non-current acquired | |||||
| Note receivable from property held for sale | |||||
| Deferred income taxes acquired | |||||
| Other non-current liabilities acquired | |||||
| Supplemental disclosure of noncash financing activities: | |||||
| Paycheck Protection Program loan forgiveness | |||||
| Excise tax on purchases of common stock | |||||
| Cboe Digital investor member revenue asset | |||||
| Cboe Digital non-recourse notes and warrants | |||||
| Reconciliation of cash, cash equivalents, and restricted cash and cash equivalents: | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents (included in margin deposits, clearing funds, and interoperability funds) | |||||
| Restricted cash and cash equivalents (included in cash and cash equivalents) | |||||
| Restricted cash and cash equivalents (included in other current assets) | |||||
| Customer bank deposits (included in margin deposits, clearing funds, and interoperability funds) | |||||
Loading...